CFTC Files to Dismiss CME's Lawsuit Over Crypto Perpetual Futures
The CFTC argued in court filings that CME Group lacks standing to challenge the agency's approval of Kalshi's Bitcoin perpetual contract, saying the exchange cannot show concrete financial harm from the policy. The filing signals regulatory acceptance of DCM-listed perpetual futures.
The CFTC has filed to dismiss CME Group's legal challenge to the agency's approval of Kalshi's Bitcoin perpetual contract, arguing the exchange lacks the standing to mount such a case. In a motion filed with the court, according to reporting by The Block, Cointelegraph, and Decrypt, the CFTC's lawyers called the lawsuit "much ado about nothing," contending that CME cannot show it suffered any concrete financial injury under the CFTC's policies on crypto perpetual futures.
The filing represents a critical moment in the regulatory dispute over which entities may list cryptocurrency derivatives. CME challenged Kalshi's product after the CFTC approved it, but the agency's response narrows the grounds on which an exchange can block a competitor's offering through litigation.
According to Decrypt's reporting, the CFTC argues that CME cannot challenge its approval without demonstrating tangible harm from the agency's crypto perpetual futures policies. Cointelegraph reported the same jurisdictional argument: CME Group cannot show financial injury sufficient to establish standing. The Block's account framed the CFTC's position as a broad rejection of CME's competitive claim.
The CFTC's motion to dismiss, if granted, would signal regulatory acceptance of designated contract markets (DCMs) listing perpetual futures on crypto assets. Such approval could open the door for other exchanges to launch similar products without facing the same litigation barriers CME deployed against Kalshi.
The open questions include the timeline for judicial ruling on the CFTC's dismissal motion, whether CME has grounds to appeal or refile with different injury claims, and whether this CFTC position will apply uniformly to other DCM crypto derivatives offerings beyond Kalshi's product.
The CFTC's lawyers called CME's lawsuit 'much ado about nothing,' arguing the exchange cannot demonstrate financial injury under the CFTC's crypto perpetual futures policies.
The success of the CFTC's dismissal motion would remove a significant litigation barrier to crypto derivatives approval at other DCMs. CME's next move, and whether the court grants the motion, will determine whether competitive exchanges can block rival crypto products or whether the CFTC's approval authority stands unchallenged.
Ranked, source-checked, and verified by the desk's independent review pass.
Sources
Also reported by CoinDesk, Decrypt, Cointelegraph. The desk cites only the pages it drew facts from; these outlets independently carried the same development.
More on CFTC
Other reporting from this desk on CFTC.
- CFTC staff warns prediction markets on mention contracts, cites insider-trading risk · September 23, 2026 · 7:12 PM ET
- CFTC Files Crypto Market Rulemaking With White House at Prerule Stage · September 19, 2026 · 7:13 PM ET
- SEC and CFTC pledge crypto rules without Congress after Clarity Act fails · September 16, 2026 · 8:34 PM ET
- Senate Fails Clarity Act Cloture Vote on September 15; Ethics Divide Kills Crypto Bill · September 15, 2026 · 3:32 PM ET